Amanta Healthcare IPO Date, Review, Price, Allotment Details
The opening date of the Amanta Healthcare IPO is September 1, 2025, and IPO will close on September 3, 2025. Amanta Healthcare IPO is a Book Built Issue. The company plans to issue approximately 126 crores through IPO, including a fresh issue of 126 crores and also through an offer to sale up to [.] shares with a face value of 10 each.
The price band of the Amanta Healthcare IPO is 120 to 126. The retail quota is 35, QIB 50 percent and HNI 15 percent. Amanta Healthcare IPO will list on the BSE and NSE on 8 September 2025. The Amanta Healthcare IPO date is the 4th of September 2025.
In 2025, the company registered revenue of 276.09 crores as compared to 281.61 crores in 2024. Profit in the company stood at 10.50 crores in 2025 compared to a profit of 3.63 crores in 2024. The IPO investors are expected to employ the IPO in the long term as per the financials.
Amanta Healthcare IPO Details
| IPO Open Date: | September 1, 2025 |
| IPO Close Date: | September 3, 2025 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹120 to ₹126 Per Share |
| Issue Size: | Approx ₹126 Crores |
| Fresh Issue: | Approx ₹126 Crores |
| Lot Size: | 119 Shares |
| Issue Type: | Book Built Issue |
| IPO Listing: | BSE & NSE |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
Amanta Healthcare IPO Market Lot
The minimum market lot in Amanta Healthcare IPO is 119 shares and has ₹14,994 application amount. The retail investors are capable of issuing up to 13 lots of 1547 shares of 194922 value.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 119 | ₹14,994 |
| Retail Maximum | 13 | 1,547 | ₹1,94,922 |
| S-HNI Minimum | 14 | 1,666 | ₹2,09,916 |
| B-HNI Minimum | 67 | 7,973 | ₹10,04,598 |
Amanta Healthcare IPO Dates
Amanta Healthcare IPO date will be 2025 and the date will be 2025. Allotment of Amanta Healthcare IPO will be completed in 2025, and the IPO listing in 2025.
| IPO Open Date: | September 1, 2025 |
| IPO Close Date: | September 3, 2025 |
| Basis of Allotment: | September 4, 2025 |
| Refunds: | September 5, 2025 |
| Credit to Demat Account: | September 5, 2025 |
| IPO Listing Date: | September 8, 2025 |
Promoters of Amanta Healthcare
Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel, and Milcent Appliances Private Limited are the promoters of the firm.
Business Overview
Amanta Healthcare Limited is one of the major pharmaceutical companies that deal with the development, manufacture and marketing of a broad variety of sterile liquid products, primarily parenterals, which was established in December 1994. These are filled in plastic containers using the high-tech Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. Some of the fluid therapy products made by the company include IV fluids, diluents, eye drops, and respiratory care solutions.
Irrigation solutions, first-aid products, and eye lubricants are also manufactured under the medical device segment by Amanta Healthcare. The company markets its products through three business divisions: National Sales, International Sales, and Product Partnerships with various Indian and foreign pharmaceutical companies. The company manufactures more than 45 generic products under its own brand and sells them in India with 320 distributors and stockists. As of March 31, 2025, the company has a total of 1,718 employees.
Amanta Healthcare Financial Report
In 2025, the company recorded its revenue at 276 crores as compared to 282 crores in 2024. The company achieved a profit of 10.50 crores in the year 2025 as compared to 3.63 crores in 2024.
Amount in Crores (₹)
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹263 | ₹206 | ₹2.11 | ₹374 |
| 2024 | ₹282 | ₹223 | ₹3.63 | ₹352 |
| 2025 | ₹276 | ₹215 | ₹10.50 | ₹382 |
Amanta Healthcare IPO Valuation – FY2025
Check Amanta Healthcare IPO valuation details like Earnings Per Share (EPS), Price/Earnings Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 12.42% |
| ROCE: | 13.72% |
| EBITDA Margin: | 22.11% |
| PAT Margin: | 3.86% |
| Debt-to-equity ratio: | 2.02 |
| Earning Per Share (EPS): | ₹3.71 (Basic) |
| Price/Earning Ratio: | N/A |
| Return on Net Worth (RoNW): | 10.89% |
| Net Asset Value (NAV): | ₹33.43 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Denis Chem Lab Limited | 5.82 | 15.92 | 9.49% | 61.33 | 176 Cr. |
Objects of the Issue
- Providing capital expenditure capital is needed to carry out the work of civil construction and to purchase equipment, plant and machinery to install a new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat.
- Funding capital expenditure requirements on civil construction work and acquisition of equipment, plant and machinery to establish a new manufacturing line at SVP at Hariyala, Kheda, Gujarat.
- General Corporate Purposes
Amanta Healthcare IPO Registrar
MUFG Intime India Pvt. Ltd.
Phone: +91-22-4918 6270
Email: amantahealthcare.ipo@linkintime.co.in
Website: https://in.mpms.mufg.com/
IPO Lead Managers aka Merchant Bankers
- Beeline Capital Advisors Pvt. Ltd.
Company Address
Amanta Healthcare Ltd.
8th Floor, Shaligram Corporates
C.J. Marg, Ambli,
Ahmedabad, Gujarat, 380058
Phone: 079 67777600
Email: cs@amanta.co.in
Website: https://www.amanta.co.in/